Skip to content
Legacy Wager World

Patients Discontinuing Weight-Loss Medications Put On Weight Far More Rapidly Than Dieters

Image of medical syringe and scale
Weight management often requires long-term strategies.

New research indicates that individuals who come off new weight-loss injections like semaglutide or tirzepatide may regain reduced body mass at a significantly accelerated pace than those who stop conventional lifestyle regimens.

Findings released in a leading medical journal shows that while overweight people frequently drop a large proportion of their body weight while undergoing treatment, the weight comes back at an estimated rate of nearly a kilo each month upon discontinuation.

"People buying these treatments must be aware of the danger of fast rebound weight gain when the treatment is stopped," cautioned lead investigator Dr. Susan Jebb.

This pace of regain implies a reversion to starting mass in about a year and a half.

Comparing Approaches

The analysis, which looked at 37 of trials involving over 9,000 of patients, compared the results of GLP-1 agonists with other pills.

The team note that people who shed pounds through lifestyle changes alone generally have a slower creep back—around 0.1 kg a month—after stopping.

The Reason for the Rapid Rebound

Doctors propose the mode of action of the injections explains the accelerated rebound.

These medications mimic a natural hormone called GLP-1, which moderates appetite.

"Long-term administration of the hormone levels far above than normal could lead to the system to produce less of its own natural GLP-1, and may also reduce responsiveness to its actions," said Dr. Adam Collins, a nutrition expert.

"Withdrawal of this GLP-1 'fix' means hunger is no longer kept in check, making binge eating a significant risk."

A Lifelong Condition?

Health authorities suggest the jabs for people with weight-linked health risks, accompanied by recommended lifestyle changes.

Professionals say that, given the likelihood of relapse, the treatment should be considered life-long.

This opinion is echoed by pharmaceutical companies, who note that the findings "highlight the chronic nature of obesity," comparing it to managing diseases like high blood pressure.

Patient Experiences

Individuals who have come off the jabs describe a intense return of cravings.

"It was like a trigger flipping and you become starving," said a patient.

This difficulty is worsened if individuals have not developed lasting dietary or behavioural modifications during therapy.

Growing Use

Figures suggest that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with interest being substantial.

  • Use is higher among women compared to men.
  • The middle-aged age group shows the greatest usage rates.
  • Many access the drugs through private prescriptions rather than the NHS.

Ultimately, clinicians caution that while these medications are effective agents for shedding pounds, they are not a magic fix and long-term success likely depends on ongoing lifestyle management.

KS
About the author

Kenneth Smith

A seasoned sports analyst with over a decade of experience in predictive modeling and betting strategy development.

Legacy Wager World

Type to search articles.